ABCZF
Price
Loading...
Change
-$0.00 (-0.00%)
Updated
Loading...
Capitalization
5.12B
SLN
Price
$4.79
Change
-$0.21 (-4.20%)
Updated
Feb 21 closing price
Capitalization
208.22M
Ad is loading...

ABCZF vs SLN

Header iconABCZF vs SLN Comparison
Open Charts ABCZF vs SLNBanner chart's image
Abcam
PriceLoading...
Change-$0.00 (-0.00%)
VolumeN/A
Capitalization5.12B
Silence Therapeutics
Price$4.79
Change-$0.21 (-4.20%)
Volume$137.27K
Capitalization208.22M
ABCZF vs SLN Comparison Chart
Loading...
SLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABCZF vs. SLN commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCZF is a Hold and SLN is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (ABCZF: $22.25 vs. SLN: $4.79)
Brand notoriety: ABCZF and SLN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCZF: 100% vs. SLN: 35%
Market capitalization -- ABCZF: $5.12B vs. SLN: $208.22M
ABCZF [@Biotechnology] is valued at $5.12B. SLN’s [@Biotechnology] market capitalization is $208.22M. The market cap for tickers in the [@Biotechnology] industry ranges from $393.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCZF’s FA Score shows that 1 FA rating(s) are green whileSLN’s FA Score has 0 green FA rating(s).

  • ABCZF’s FA Score: 1 green, 4 red.
  • SLN’s FA Score: 0 green, 5 red.
According to our system of comparison, both ABCZF and SLN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SLN’s TA Score shows that 5 TA indicator(s) are bullish.

  • SLN’s TA Score: 5 bullish, 3 bearish.

Price Growth

ABCZF (@Biotechnology) experienced а 0.00% price change this week, while SLN (@Biotechnology) price change was -1.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.71%. For the same industry, the average monthly price growth was -2.01%, and the average quarterly price growth was +0.86%.

Reported Earning Dates

SLN is expected to report earnings on May 14, 2024.

Industries' Descriptions

@Biotechnology (-1.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABCZF($5.12B) has a higher market cap than SLN($208M). ABCZF YTD gains are higher at: 0.000 vs. SLN (-30.378).
ABCZFSLNABCZF / SLN
Capitalization5.12B208M2,462%
EBITDAN/A-56.89M-
Gain YTD0.000-30.378-
P/E Ratio1770.50N/A-
RevenueN/A16.2M-
Total CashN/A129M-
Total DebtN/A139K-
FUNDAMENTALS RATINGS
ABCZF: Fundamental Ratings
ABCZF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
PROFIT vs RISK RATING
1..100
75
SMR RATING
1..100
85
PRICE GROWTH RATING
1..100
70
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SLN
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 4 days ago
90%
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
82%
View a ticker or compare two or three
Ad is loading...
SLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GABOX12.19N/A
N/A
Gabelli International Small Cap AAA
FZABX27.34N/A
N/A
Fidelity Advisor Diversified Intl Z
ASVGX10.78N/A
N/A
American Century Small Cap Value R5
ARVIX11.08N/A
N/A
ARGA International Value Institutional
JDVAX15.86-0.14
-0.88%
JPMorgan Diversified A

ABCZF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCZF has been closely correlated with IKNA. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if ABCZF jumps, then IKNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCZF
1D Price
Change %
ABCZF100%
N/A
IKNA - ABCZF
72%
Closely correlated
-4.14%
ATRA - ABCZF
69%
Closely correlated
-5.45%
CMVLF - ABCZF
62%
Loosely correlated
N/A
CLLS - ABCZF
58%
Loosely correlated
-0.65%
NUVL - ABCZF
52%
Loosely correlated
-3.52%
More